Efficacy and Safety of CUSA-081 in the Restoration of Central Venous Access Device (CVAD) Functionality

NCT03594175 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

462

Enrollment

INDUSTRY

Sponsor class

Stopped Due to ongoing recruitment challenges globally, it is not possible to complete this study. The decision is not based on any reported changes in the safety profile or any concerns with the anticipated efficacy profile of the investigational product.

Conditions

Catheter Occlusion
Thrombosis

Interventions

DRUG: CUSA-081
DRUG: Placebo
DRUG: Alteplase

Sponsor

Chiesi Farmaceutici S.p.A.